In acute herpes simplex virus type 2 infection, how long after exposure does a diagnostic test become positive?

HSV-2 Serology Timing in Acute Infection

HSV-2 antibody testing requires at least 12 weeks after exposure to become reliably positive; testing before this window is clinically meaningless and will miss most acute infections. 1, 2

Antibody Development Timeline

The critical window for HSV-2 seroconversion is substantially longer than most clinicians expect:

• Detectable IgG antibodies typically do not appear until up to 12 weeks (3 months) after initial HSV-2 exposure. 1, 2
• The median time to antibody detection is approximately 13 days in research settings using sensitive assays, but this represents the earliest possible detection—not the norm. 3
• Index values tend to peak at a median of 9-10 weeks post-infection (range 8-323 days). 4
• Testing performed at 3-4 weeks post-exposure has essentially unknown accuracy but is presumed to be substantially lower than baseline because most patients have not yet seroconverted. 2

Test Performance at Optimal Timing (≥12 Weeks)

Even when performed at the recommended ≥12-week timepoint, HSV-2 serology has significant limitations:

• HSV-2 IgG assays achieve approximately 92% sensitivity, meaning they still miss about 8% of true infections. 1, 2
• HSV-1 serology performs even worse, with only 70% sensitivity (30% false-negative rate). 1, 2
• Specificity for HSV-2 is poor at low index values (1.1-2.9), dropping to approximately 39.8%; it improves to 78.6% at index values ≥3.0 but remains suboptimal. 1, 2
• Patients with prior HSV-1 infection are particularly prone to false-positive HSV-2 results when index values are low. 1, 2

Critical Clinical Pitfalls

Do not order serology to diagnose acute genital lesions—this is the most common and consequential error. 1, 2

When active lesions are present:

• Perform HSV nucleic acid amplification testing (NAAT/PCR) directly from the lesion; this achieves >90% sensitivity and specificity and is the gold-standard diagnostic method. 1, 2
• NAAT/PCR is vastly superior to viral culture, which loses sensitivity as lesions heal. 1
• Direct immunofluorescence and Tzanck smears are not recommended due to inadequate sensitivity. 1

When no lesions are present:

• Wait until ≥12 weeks after suspected exposure before ordering type-specific HSV-2 IgG serology. 1, 2
• A negative result obtained before 12 weeks is unreliable and should prompt repeat testing after the 12-week window. 1, 2
• Never tell patients that a negative serology definitively excludes HSV-2 infection, even at optimal timing. 1, 2

Confirmatory Testing Considerations

When HSV-2 serology yields a low-positive result (index 1.1-2.9):

• Consider confirmatory testing because specificity in this range is only 39.8%. 1, 2
• Western blot/immunoblot remains the gold-standard confirmatory test but is generally limited to research laboratories. 1, 2
• This is especially important in patients with prior HSV-1 infection, who have higher rates of false-positive HSV-2 results. 1, 2

Practical Algorithm for HSV-2 Testing

If lesions are present:

• Order HSV NAAT/PCR that distinguishes HSV-1 from HSV-2 from the lesion. 1, 2
• Do not order serology. 1, 2

If no lesions are present and exposure occurred <12 weeks ago:

• Defer serologic testing. 1, 2
• Repeat testing at ≥12 weeks post-exposure. 1, 2
• If lesions develop before 12 weeks, obtain NAAT/PCR from the lesion. 1, 2

If no lesions are present and exposure occurred ≥12 weeks ago:

• Order type-specific HSV-2 IgG serology (EIA or CLIA assays detecting glycoprotein G-2). 1, 2
• If index value is 1.1-2.9, consider confirmatory testing due to poor specificity. 1, 2
• If negative and clinical suspicion remains high, recognize the 8% false-negative rate for HSV-2. 1, 2